Tulsa Dangerous Drug Lawyers

On Tuesday, April 21st, Attorney Chad McLain of Graves McLain appeared via Skype on KTUL’s Good Day Tulsa program to discuss mass tort lawsuits. Watch the segment: Many people are harmed by dangerous drugs or ...

Recently, an $85 million settlement between Teva Pharmaceuticals and the state of Oklahoma was signed by Cleveland County District Judge Thad Balkman. The state maintained that Teva utilized deceptive marketing claims to promote opioids as ...

A Cleveland County District Judge has ruled he will decide Oklahoma's case against several drug manufacturers for their alleged complicity in the opioid crisis currently gripping the United States in a bench trial. District Judge ...

Purdue, the manufacturer of the controversial opioid OxyContin, settled a lawsuit brought by the Oklahoma Attorney General for $270 million. A detailed article on the nature of the landmark settlement is available here. A suit ...

Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According ...

Drug manufacturer Camber Pharmaceuticals has issued a recall for large quantities of Losartan. An article on this emerging story is available here. Currently, no patients have reported any adverse effects related to potential contamination. Patients ...

Several medications containing the active ingredient Valsartan have been recalled by the United States Food and Drug Administration over contamination issues. The impurity, known as N-nitrosodimethylamine (NDMA), is classified as a probable human carcinogen. The ...

Nearly three years ago, two juries in Philadelphia awarded compensatory damages to clients in two lawsuits against Janssen Pharmaceuticals’ drug Risperdal. Now, both cases are proceeding toward new trials to determine punitive damages. A detailed ...

The Food and Drug Administration (FDA) announced on Tuesday, 7/26 that they are revising their boxed warning labels on packages of a class of antibacterial drugs known as fluoroquinolones. The FDA’s boxed warning labels, commonly ...

The Food and Drug Administration just issued another Drug Safety Communication alerting doctors and patients about serious health risks associated with several type 2 diabetes medications, including Invokana. The FDA is strengthening warnings about the ...